Regulation of rbST in the US

AgBioForum

Volumn 3, Issue 2-3, 2000, Pages 156-163

  Collier, Robert ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Dairy cattle; Public acceptance; Regulatory process; Somatotropin

Indexed keywords

BOS TAURUS; BOVINAE;

EID: 3042532344     PISSN: 1522936X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Asimov, G.J. and Krouze, N.K. (1937). The lactogenic preparations from the anterior pituitary and the increase in milk yield from cows. Journal of Dairy Science, 20, 289-306.
2. Bauman, D.E. (1992). Bovine somatotropin. Review of an emerging animal technology. Journal of Dairy Science, 75, 1514-1529.
3. Bauman, D.E., Eppard, P.J., DeGeeter, M.J., and Lanza, G.M. (1985). Responses of high-producing dairy cows to long term treatment with pituitary somatotropin and recombinant somatotropin. Journal of Dairy Science, 68(6), 1352-1362.
4. Bauman, D.E., Everett, R.W., Weiland, W.H., and Collier, R.J. (1999). Production responses to bovine somatotropin in Northeast dairy herds. Journal of Dairy Science, 82(12), 2564-2573.
5. Collier, R.J. (1993, March). Paper presented at the Food and Drug Administration Veterinary Medicine Advisory Committee Hearing on Bovine Somatotropin (Sometribove). Gaithersburg, MD.
6. Collier, R.J., Vicini, J.L., Knight, C.D., McLaughlin, C.L., and Baile, C.A. (1992). Impact of somatotropins on nutrient requirements in domestic animals. Journal of Nutrition, 122, 855-860.
7. Cotes, P.M., Crichton, J.A., Folley, S.J., and Young, F.G. (1949). Galactopoietic activity of anterior pituitary growth hormones. Nature, 164, 992-998.
8. General Accounting Office (GAO). (1994). Report B-248450 of August 6, 1992: Recombinant bovine growth hormone, FDA approval should be withheld until the mastitis issue is resolved (Report B-257122 to Members of the House of Representatives referring to GAO/PEMD-92-96). Washington DC: GAO.
9. Hammond, B.G., Collier, R.J., Miller, M.A., McGrath, M., Hartzell, D.L., Kotts, C., and Vandaele. W. (1990). Food safety and pharmacokinetic studies which support a zero (0) meat and milk withdrawal time for use of sometribove in dairy cows. Annals of Veterinary Research, 21, 107-120.
10. Judge, L.J., Erskine, R.J., and Bartlett, P.C. (1997). Recombinant bovine somatotropin and clinical mastitis: Incidence, discarded milk following therapy and culling. Journal of Dairy Science, 80, 3212-3218.
11. Juskevich, J.C. and Guyer, C.G. (1990). Bovine growth hormone: Human food safety evaluation. Science, 249, 875-884.
12. Kalter, R.J., Milligan, R., Lesser, W., Magrath, W., Tauer, L., and Bauman, D. (1985). Biotechnology and the dairy industry: Production costs and commercial potential, and the economic impact of the bovine growth hormone. Paper prepared for the Cornell University Center for Biotechnology, Committee for Economic Development, A.E. Research 85-120. Ithaca, New York.
13. Kusserow, R.P. (1992). Audit of issues related to the food and drug administration review of bovine somatotropin (Department of Health and Human Services (DHHS) Publication A-15-90-00046). Washington DC: DHHS.
14. Leonard-Barton, D. and Pisano, G. (1993). Monsanto's march into biotechnology (A). Harvard Business School Review, No. 9-690-009, 1-18.
15. Machlin, L.J. (1972). Effect of growth hormone on milk production and feed utilization in dairy cows. Journal of Dairy Science, 56, 575-580.
16. National Institute of Health (NIH). (1991). NIH technology assessment conference statement on bovine somatotropin. Journal of the American Medical Association, 265,1423-1425.
17. Office of Technology Assessment (OTA). (1992). US industry at a crossroad: Biotech and policy (part 1 of 5). Washington, DC: Congress of the United States, OTA.
18. Ruegg, P.L., Fabellar, A., and Hintz, R.L. (1998). Effect of the use of bovine somatotropin on culling practices in thirty-two dairy herds in Indiana, Michigan and Ohio. Journal of Dairy Science, 81, 1262-1266.
19. Tauer, L.W. and Knoblauch, W.A. (1997). The empirical impact of bovine somatotropin on New York dairy farms. Journal of Dairy Science, 80, 1092-1097.
20. Van Amburgh, M.E., Galton, D.M., Bauman, D.E., and Everett, R.W. (1997). Management and economics of extended calving intervals with use of bovine somatotropin. Livestock Production Science, 50,15-28.
21. White, T.C., Madsen, K.S., Hintz, R.L., Sorbet, R.H., Collier, R.J., Hard, D.L., Hartnell, G.F., Samuels, W.A., de Kerchove, G., Adriaens, F., Craven, N., Bauman, D.E., Bertrand, G., Bruneau, P.H., Gravert, G.O., Head, H.H., Huber, J.T., Lamb, R.C., Palmer, C., Pell, A.N., Phipps, R., Weller, R., Piva, G., Rijpkema, Y., Skarda, J., Vedeau, F., and Wollney, C. (1994). Clinical mastitis in cows treated with Sometribove (recombinant bovine somatotropin) and its relationship to milk yield. Journal of Dairy Science, 77, 2249-2260.
22. Young, F.G. (1947). Experimental stimulation (galactopoiesis) of lactation. British Medical Bulletin, 5, 155-160.